← Leaderboards
Philana Ling Lin
University Of Pittsburgh At Pittsburgh
$10,232,778
Attributed
$18,115,404
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,115,404 · 9
By mechanism
R01$16,143,119 · 5
R56$787,116 · 1
K08$584,150 · 1
R21$431,686 · 1
R03$169,333 · 1
Top collaborators
- Joanne L. Flynn13 shared
- Zandrea Ambrose5 shared
- Pleuni Pennings5 shared
- Sarah M Fortune1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Joanne L. Flynn$43,717,509
- Kirk I Erickson$29,375,219
- Eric Joseph Rubin$20,208,402
- Charles A. Scanga$10,882,031
- Joshua T. Mattila$2,064,710
Others in their field
Top investigators on “Immune Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,695,345
- Barton F Haynes · Duke University$456,664,915
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$309,708,725
- Peter B. Gilbert · Fred Hutchinson Cancer Center$192,329,665
Research focus
Immune ResponseMycobacterium TuberculosisTuberculosisInfectionGranulomaImmuneSiteCessation Of LifeImmunologicsAnimal ModelVaccinesResponseCellsAnimalsInsightNonhuman PrimateBacteriaHiv InfectionsPathogenTissuesPreventionCo-InfectionMolecularHigh Risk
Grant awards (30)
Oral BCG: Optimizing mucosal vaccination against tuberculosis$1,162,224
R01 · FY2025 · AI · contact PI
Enhancing cytotoxic lymphocytes in a TB vaccine strategy$728,788
R01 · FY2025 · AI
Enhancing cytotoxic lymphocytes in a TB vaccine strategy$762,587
R01 · FY2024 · AI
Dissecting the pathogenesis of HIV-TB Immune reconstitution inflammatory syndrome$739,545
R01 · FY2024 · AI · contact PI
Enhancing cytotoxic lymphocytes in a TB vaccine strategy$773,531
R01 · FY2023 · AI
Dissecting the pathogenesis of HIV-TB Immune reconstitution inflammatory syndrome$750,630
R01 · FY2023 · AI · contact PI
Enhancing cytotoxic lymphocytes in a TB vaccine strategy$772,170
R01 · FY2022 · AI
Dissecting the pathogenesis of HIV-TB Immune reconstitution inflammatory syndrome$763,732
R01 · FY2022 · AI · contact PI
Influence of SIV replication on TB progression and immunity$945,816
R01 · FY2021 · AI
Dissecting the pathogenesis of HIV-TB Immune reconstitution inflammatory syndrome$765,082
R01 · FY2021 · AI · contact PI
Influence of SIV replication on TB progression and immunity$1,023,452
R01 · FY2020 · AI
Dissecting the pathogenesis of HIV-TB Immune reconstitution inflammatory syndrome$775,815
R01 · FY2020 · AI · contact PI
Influence of SIV replication on TB progression and immunity$1,029,305
R01 · FY2019 · AI
Influence of SIV replication on TB progression and immunity$933,104
R01 · FY2018 · AI
Contribution of CD8 T cells in Controlling Tuberculosis$787,116
R56 · FY2018 · AI · contact PI
HIV-TB Co-infection: Tracking TB emergence after asymptomatic (latent) infection$615,075
R01 · FY2018 · AI · contact PI
Influence of SIV replication on TB progression and immunity$888,791
R01 · FY2017 · AI
HIV-TB Co-infection: Tracking TB emergence after asymptomatic (latent) infection$676,755
R01 · FY2017 · AI · contact PI
Host and Pathogen Diversity in Mtb and SIV Infection$241,843
R21 · FY2017 · AI · contact PI
The Effects of M. tuberculosisInfection on Lung Microbiome in Macaques$77,968
R03 · FY2017 · AI
HIV-TB Co-infection: Tracking TB emergence after asymptomatic (latent) infection$678,045
R01 · FY2016 · AI · contact PI
Host and Pathogen Diversity in Mtb and SIV Infection$189,843
R21 · FY2016 · AI · contact PI
The Effects of M. tuberculosisInfection on Lung Microbiome in Macaques$91,365
R03 · FY2016 · AI
HIV-TB Co-infection: Tracking TB emergence after asymptomatic (latent) infection$679,336
R01 · FY2015 · AI · contact PI
HIV-TB Co-infection: Tracking TB emergence after asymptomatic (latent) infection$679,336
R01 · FY2014 · AI · contact PI
TNF and Granuloma Formation in Tuberculosis$120,717
K08 · FY2009 · AI · contact PI
TNF and Granuloma Formation in Tuberculosis$120,148
K08 · FY2008 · AI · contact PI
TNF and Granuloma Formation in Tuberculosis$117,193
K08 · FY2007 · AI · contact PI
TNF and Granuloma Formation in Tuberculosis$114,401
K08 · FY2006 · AI · contact PI
TNF and Granuloma Formation in Tuberculosis$111,691
K08 · FY2005 · AI